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1. Introduction
  Diabetes mellitus type 2 is a metabolic disorder, and has 
become a thoughtful problem of modern society due to the 
severe long term health complications associated with it. 
This is the most encountered form of diabetes, accounting 
for more than 80% of the total cases of diabetes[1]. 
Oxidative stress in diabetes coexists with a reduction in 
the antioxidant status[2], which ultimately increases the 
deleterious effects of free radicals[3]. Streptozotocin (STZ) 
induces its diabetogenic activity mainly by inducing 
oxygen free radical and causing necrosis of the pancreas[3]. 
Both the radical and non-radical oxidants can induce 
lipid peroxidation particularly of those lipoproteins that 
contain unsaturated fatty acids, which in turn stimulates 
glycation of protein, inactivation of enzymes and alteration 
in the structure and function of collagen, basement 
and other membranes and play a role in the long term 
complications of diabetes[4,5]. Increased oxidative stress in 
diabetes mellitus may also be a reason for such decrease 
in erythrocytes count. Hyperglycemia can burden the 
cells with extra free radicals[6]. This coupled with reduced 
glutathione (GSH) content secondary to its increased 
utilization in diabetic erythrocytes can cause peroxidative 
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breakdown of phospholipids fatty acids in the erythrocytes 
membrane[7]. It is noted that erythrocytes of diabetic patients 
are more susceptible to lipid peroxidation when treated with 
hydrogen peroxide in vitro[8].
  Antioxidants play an important protective role against 
the reactive oxygen species. Reports indicate that there 
is an inverse relationship between the dietary intake 
of antioxidant-rich foods and the incidence of human 
diseases[9]. 
  Emblica officinais (E. officinalis; Family: Euphorbiaceae) 
are used in Ayurveda as a potent rasayanas, a class of plant-
derived drugs reputed to promote health and longevity by 
increasing defense against diseases[10,11]. E. officinalis has 
been reported as a rich source of vitamin C, which plays 
an important role in scavenging free radicals[3]. This study 
was designed to evaluate the antidiabetic and antioxidant 
activities of E. officinalis in streptozotocin induced type 2 
diabetic model rats.
2. Materials and methods 
2.1. Materials and aqueous extract of E. officinalis
  E. officinalis was purchased from the local market. The 
pulp of the fruit was separated from the seed and blended. 
The resultant juice was filtered with a clean cloth and the 
supernatant separated. The aqueous extract was evaporated 
to concentrate at reduced pressure using a rotary vacuum 
evaporator at 50 曟 and finally dried using freeze-drier. 
2.2. Rats and diets
  The experimental protocol was approved by the Animal 
Studies committee of BIRDEM. Adult male Long Evans 
rats weighing approximately 180-220 g were obtained from 
BIRDEM Animal House, Dhaka, Bangladesh. The 32 rates 
were randomly divided into four groups: normal control 
group (n=8) fed with deionized water at a dose of 10 mL/kg
body weight; non-insulin dependent diabetes mellitus 
(NIDDM) control group (n=8) fed with deionized water at 
a dose of 10 mL/kg body weight; NIDDM positive control 
group(n=8) treated with glibenclamide at a dose of 5 mg/10 mL
(9.9 mL H2O + 0.1 mL Twin 20)/kg body weight; NIDDM 
treated group (n=8) fed with aqueous extract of E. officinalis 
at a dose of 1.25 g/10 mL/ kg body weight. The animals 
were bred at BIRDEM Animal house, Dhaka, Bangladesh 
maintained at a constant room temperature of (22依5) 曟 with 
humidity of 40%-70% and the natural 12 h day-night cycle. 
The rats were fed on a standard laboratory pellet diet and 
water supplied ad libitum.
  Type 2 diabetes was induced by a single intraperitoneal 
injection of streptozotocin (STZ) at a dose of 90 mg/kg body 
weight) in citrate buffer (10 mL) to the 48 h old rat pups 
(approximately 7 g) as described by Bonner-Weir et al[12]. 
Experiments were carried out 3 months after STZ injection 
and rats having blood glucose level 8-12 mmol/L at fasting 
conditions, these were taken to carry out the experiments. 
Body weight, food and water intakes were observed at 
regular intervals for all rats.
2.3. Biochemical analysis 
  Blood samples were collected on 0 day from the tail tips 
for different biochemical analysis, on the 28th day post-
prandial blood glucose level was determined and the rats 
were decapitated on the 56 day after 12 h fasting. Blood 
samples were collected in heparinized tubes for estimation 
of malondialdehyde (MDA) and reduced GSH. Serum glucose 
was estimated by glucose oxidase (GOD-PAP, Boheringer 
Mannheim GmbH), serum triglyceride and cholesterol 
by enzymatic-colorimetric, creatinine and alanine 
aminotransferase (ALT) by Automatic Analyzer and serum 
insulin by an ELISA. Packed red cells were used for the 
estimation of MDA by using the thiobarbituric acid method 
and GSH was assayed by Ellman’s method[13].
2.4. Statistical analysis 
  All data sets were expressed as mean依SD or as median 
(Range) as appropriate. Data were also statistically analyzed 
using the student’s t-test (paired and unpaired) or ANOVA 
(analysis of variance) followed by Bonferroni post hoc test 
or Mann Whitney (U) test. The differences were considered 
significant at P<0.05.
3. Results 
3.1. Effect of aqueous extract of E. officinalis on glucose 
homeostasis
  Results of fasting serum glucose (FSG) level of the studied 
rats at baseline (before onset of feeding i.e., 0 day) and 56 
day of feeding is presented in Table 1.
  At baseline FSG (mmol/L) of type 2 water, glibenclamide 
and aqueous extract of E. officinalis treated groups were 
almost similar, whereas in normal control rats FSG was (7.96
依0.27) mmol/L. As it is seen from the Table 1, on 56 day the 
FSG level of all the groups of rats decreased, although the 
decrease was not significant in normal rats. Type 2 rats fed 
with aqueous extract of E. officinalis showed a significant 
decrease while comparing within groups (t=6.497, P=0.007). 
As expected, glibenclamide also ameliorated the diabetic 
condition on 56 day (t=4.148, P=0.025). Type 2 control rats 
also significantly reduced blood glucose level (t=5.740, 
P=0.01). While comparing within groups, only glibenclamide 
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showed a significant reduction in serum glucose level on 56 
day in comparison with normal rats. 
Table 1 
Chronic effect of aqueous extract of E. officinalis on fasting blood 
glucose levels of normal and type 2 diabetic model rats.
Group
 
Glucose (mmol/L)
          0 day           56 day
NWC                  7.96依0.27       6.60依0.91
Type 2 WC      10.01依1.27       6.29依1.19
Type 2 GT         9.91依2.24       5.27依0.47
Type 2 AE       10.23依1.36       6.75依0.50
Data were expressed as Mean依SD. NWC: Normal water control, NAE: 
Normal aqueous extract of E. officinalis, Type 2 WC: Type 2 water 
control, Type 2 GT: Type 2 glibenclamide positive control, Type 2 AE: 
Aqueous extract of E. officinalis type 2 group.
3.2. Effect of aqueous extract of E. officinalis on the 
postprandial blood glucose level of type 2 diabetic model rats 
when fed simultaneously with glucose load performed on 28 
day of study period
  Table 2 shows the acute effect of aqueous extract of E. 
officinalis on the postprandial blood glucose level on 
different groups of type 2 diabetic model rats when extract 
was fed simultaneously with the glucose load on 28 day. As 
it was seen fasting serum glucose level of the type 2 extract 
fed groupwas higher [(9.38依1.10) mmol/L], while the rest of 
the groups showed almost same level of blood glucose. As it 
is seen, the percentage increase of serum glucose was 62%, 
122%, 148% and 64% in normal rats, type 2 water control 
rats, glibenclamide treated and extract treated groups, 
respectively (at 30 minutes) and at 90 minutes the rise was 
26%, 122%, 158% and 70%, respectively. Although the fasting 
glucose level of the extract treated groups was significantly 
higher than the rest of the groups on day 28, it opposed the 
rise of blood glucose at both the time points.
Table 2
Effect of aqueous extract of E. officinalis on the postprandial blood 
glucose level of type 2 diabetic model rats when fed simultaneously 
with glucose load performed on the 28th day of study period. 
Group
Glucose (mmol/L)
   0 min     30 min    90 min
NWC            6.76依0.64 10.96依3.31   8.51依1.04 
Type 2 WC  7.43依0.82 16.50依1.70 16.48依3.91 
Type 2 GT   7.01依2.23 17.38依2.62 18.10依2.61 
Type 2 AE   9.26依0.95 15.22依3.58 15.75依1.01 
Data were expressed as Mean依SD. NWC: Normal water control, NAE: 
Normal aqueous extract of E. officinalis, Type 2 WC: Type 2 water 
control, Type 2 GT: Type 2 glibenclamide positive control, Type 2 AE: 
Aqueous extract of E. officinalis type 2 group.
3.3. Chronic effect of aqueous extracts of E. officinalis on the 
serum cholesterol and triglyceride levels of normal and type 2 
diabetic model rats
  As shown in Table 3, the effect of aqueous extract of E. 
officinalis on the total serum cholesterol and triglyceride 
levels of normal water treated and type 2 diabetic model rats. 
It is evident that type 2 water treated group had an increase 
of 8% in the total serum cholesterol level at the end of study 
period. However, glibenclamide treated type 2 rats showed a 
decrease in the total serum cholesterol after 56 days feeding 
by 4%. In case of the type 2 treated extract group, there was 
a 5% increase in comparison to the 0 day value. Virtually, 
there was no significant change in the total cholesterol level 
at the end of the study period. 
  In case of serum triglyceride level, it is seen that other than 
type 2 water treated group (which has in increase in of 1%), 
the rest had a fall in the triglyceride levels (i.e. 20% decrease 
in normal water fed rats, 8% in type 2 glibenclamide treated 
rats and 14% in extract treated type 2 rats). 
Table 3
Chronic effect of aqueous extracts of E. officinalis on the serum 
cholesterol and triglyceride levels of normal and type 2 diabetic model 
rats. 
Group
     Cholesterol (mg/dL) TG (mg/dL)
0 day 56 day 0 day 56  day
NWC 61依5 62依8 69依6   55依19 
Type 2 WC  60依4 65依8   56依15   57依10
Type 2 GT   60依7   58依10   66依19   61依19
Type 2 AE   56依5 59依5   64依19 55依3 
Data were expressed as Mean依SD. NWC: Normal water control, NAE: 
Normal aqueous extract of E. officinalis, Type 2 WC: Type 2 water 
control, Type 2 GT: Type 2 glibenclamide positive control, Type 2 AE: 
Aqueous extract of E. officinalis type 2 group.
3.4. Chronic effect of aqueous extracts of E. officinalis on 
creatinine and ALT levels of normal and type 2 diabetic 
model rats
  Effect on serum creatinine and ALT is presented in Table 
4. Serum creatinine and ALT levels remained steady in all 
the groups. No significant change was noticed in serum 
creatinine and ALT levels after 56 day of the study period.
Table 4
Chronic effect of aqueous extracts of E. officinalis on creatinine and alt 
levels of normal and type 2 diabetic model rats.
Group
Creatinine (mg/dL) ALT (mg/dL)
0 day 56 day 0 day 56  day
NWC 0.70依0.04 0.90依0.04   72依24 53依7
Type 2 WC  0.80依0.00 0.90依0.01 52依7 53依9
Type 2 GT   0.80依0.05 0.80依0.07   55依14   58依15
Type 2 AE   0.80依0.04 0.90依0.02   62依11 51依4
Data were expressed as Mean依SD. NWC: Normal water control, NAE: 
Normal aqueous extract of E. officinalis, Type 2 WC: Type 2 water 
control, Type 2 GT: Type 2 glibenclamide positive control, Type 2 AE: 
Aqueous extract of E. officinalis type 2 group.
3.5. Chronic effect of aqueous extract of E. officinalis on the 
serum Insulin level of normal and type 2 diabetic model rats 
  Chronic effect of aqueous extract of E. officinalis on the 
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insulin level of normal rats fed with water and different 
groups of type 2 diabetic model rats is shown in Table 5. 
It is clearly seen that all the groups of type 2 rats had a 
significantly lower insulin level on 0 day, in comparison to 
normal rats. On day 56, serum insulin increased in normal 
control groups by 14%. Although reduction in serum insulin 
level was noticed in different groups of type 2 rats at the end 
of study period, the reduction was highest in type 2 control 
group (53% reduction) in glibenclamide treated group showed 
a fall of 15% while E. officinalis treated Type 2 rats had a 
reduction of 21%.
Table 5
Chronic effect of aqueous extract of E. officinalis on the serum insulin 
level of normal and type 2 diabetic model rats.
Group
 
Insulin (ng/dL)
0 day 56 day
NWC          (n=6) 1.32依0.34 1.51依1.26
Type 2 WC (n=5) 0.51依0.21 0.24依0.13 
Type 2 GT  (n=5) 0.25依0.04 0.21依0.06
Type 2 AE  (n=6) 0.48依0.26 0.38依0.17
Data were expressed as Mean依SD. NWC: Normal water control, NAE: 
Normal aqueous extract of E. officinalis, Type 2 WC: Type 2 water 
control, Type 2 GT: Type 2 glibenclamide positive control, Type 2 AE: 
Aqueous extract of E. officinalis type 2 group.
3.6. Chronic effect of aqueous extract of E. officinalis on 
erythrocyte MDA and reduced GSH levels of experimental rats
 The table 6 shows that the concentration of erythrocyte lipid 
peroxidation products i.e. MDA and reduced GSH in different 
groups of rats after 56 days of the study period. As expected, 
type 2 diabetic control rats exhibited the highest level of 
lipid peroxidation: erythrocyte MDA level was 27.9 (median, 
nmol/g Hb) whereas normal rats had 19.9 nmol/g Hb. The 
levels of erythrocyte MDA was significantly lower compared 
to type 2 glibenclamide treated group (P=0.01). E. officinalis 
extract administration to type 2 rats also tend to normalize 
the erythrocyte MDA level (median=20.4 nmol/g Hb) but the 
change remained just outside the significant level (P=0.078).
  As it is seen from the table, the levels of the major 
cellular antioxidant GSH was lower in type 2 control 
rats (median=5.31 mg/g Hb). The decrease GSH content 
contributes to the pathogenesis of complications associated 
with chronic diabetic state. GSH level increased significantly 
in E. officinalis extract administrated type 2 rats (median=5.9 
mg/g Hb, P=0.055). Glibenclamide treated rats also had a 
higher GSH level. 
Table 6 
Effect of aqueous extracts of E. officinalis on erythrocyte MDA and 
reduced GSH levels of normal and type 2 diabetic model rats treated 
for 2 months.
Group MDA (nmol/g Hb) GSH (mg/gm Hb)
NWC             (n=6) 19.90依0.17 5.40依0.33
Type 2 WC   (n=6)   27.90依0.23* 5.30依0.51 
Type 2 GT    (n=8)     18.20依0.42△ 5.60依0.07
Type 2 AE    (n=6) 20.40依0.13 5.90依0.29
Data were expressed as Mean依SD. NWC: Normal water control, NAE: 
Normal aqueous extract of E. officinalis, Type 2 WC: Type 2 water 
control, Type 2 GT: Type 2 glibenclamide positive control, Type 2 AE: 
Aqueous extract of E. officinalis type 2 group.
*: P<0.05, comparing with NWC; △P<0.05, comparing with Type 2 
WC.
4. Discussion 
  Diabetes produced by administration of STZ (a 毬-cell toxic 
agent) usually causes destruction of pancreatic 毬-cells[3]. 
This later improves degranulation and reduction of insulin 
secretion accompanying with hyperglycemia. The present 
study demonstrated that administration of E. officinalis 
for 8 weeks resulted in the significant (P<0.007) reduction 
of fasting serum glucose level compared to baseline level. 
The study also revealed that the reduction in serum glucose 
level was gradual. After 4 weeks administration of aqueous 
extract of Amla extract significantly increased  postprandial 
serum glucose level whereas the fasting serum glucose level 
remain unchanged in type 2 diabetes rats. Postprandial 
serum glucose increased by 62% in normal control, 122% 
in diabetic control and 148% in glibenclamide treated and 
64% in E. officinalis treated diabetic rats. Hence, the finding 
clearly demonstrates that aqueous extract of E. officinalis 
improves oral glucose tolerance in type 2 rats[10,14]. It is now 
well established that dyslipidemia plays an important role 
in the development of diabetic complication. The effects 
on diabetic complication were assessed by measuring the 
atherogenic lipids (i.e. total cholesterol and triglycerides) 
after chronic feeding of E. officinalis to diabetic rats. The 
obtained results demonstrated that total cholesterol level 
did not change by E. officinalis treatment. Conversely, 
Triglycerides level decreased 14% by administration of E. 
officinalis for 8 weeks[15,16].
  This study was carried out on STZ induced type 2 model 
rats which were hypoinsulinemic. Insulin level of normal 
rats were (1.32依0.34) ng/dL, whereas all other groups had 
almost 3 fold less insulin level. Eight weeks treatment with 
E. officinalis did not improve serum insulin level in type 2 
diabetic rats. The only difference in E. officinalis treated 
animals was less marked in insulin content (0 day: 0.48依0.26 
versus 56 day: 0.38依0.17) comparison to type 2 control rats 
[0 day: (0.51依0.21) ng/mL Versus 56 day: (0.24依0.13) ng/mL). 
Therefore, it is revealed that slowly generated hypoglycemic 
effect of E. officinalis STZ-induced type 2 rats may involve 
an extra pancreatic effect since serum insulin level did not 
increase. E. officinalis was used at a dose of 1.25 g/b.w. To 
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exclude any toxic effect of aqueous extract of Amla was 
measured on liver and kidney function, serum ALT and 
serum creatinine level were measured at the beginning and 
at the end of the study period. No significant change was 
noticed in serum ALT and creatinine level in any group of 
study rats after 8 weeks study period. Therefore, the results 
is exposed that eight weeks administration of E. officinalis 
had no toxic effect[14]. 
  Hypoinsulemia in diabetes increases the activity of acyl 
co-enzyme A oxidase which initiates 毬-oxidation of fatty 
acids resulting in lipid peroxidation[17] which is determined 
by rhiobarbuturic acid reactive (TBAR) substances level. 
Baynes (1991) and Kakkar et al (1995) reported that tissue 
blood malondialdehyde levels of rats with STZ induced 
diabetes increased due to lipid peroxidation[5,18]. Jain 
et al (1999) reported that there is a significant increased 
membrane lipid peroxidation in diabetic erythrocytes 
compared with normal erythrocytes[19]. On the basis of 
these results, the present study evaluated MDA  (TBAR) 
levels in erythrocyte homolysate to determine the degree 
of oxidative damage in diabetic rats and found that it was 
significantly higher in the diabetic control group compared 
with normal group (P=0.025). This result suggest that the 
increased malondialdehyde levels in diabetic control rats 
result in increased levels of reactive oxygen species, which 
attack poly unsaturated fatty acids in cell membranes, cause 
lipid peroxidation and subsequent development of diabetic 
complications. In contrast, orally administrated aqueous 
extract of E. officinalis reduced erythrocyte malondialdehyde 
levels in type 2 rats indicating that Amla could be a potent 
inhibitor of oxidative damage in erythrocytes[2,15].
  In this study we evaluated the antidiabetic and antioxidant 
potential of E. officinalis fruit on type 2 diabetic rats. 
The aqueous extract of E. officinalis showed potential 
antidiabetic and antioxidant properties during treatment of 
type 2 diabetic rats. This might be considered for further 
clinical studies in drug development. 
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